6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
11m ago	NervGen Announces Pricing of US$60.0 Million Public Offering of Securities
11m ago	Mitsubishi Electric Engineer Earns Kaggle Competitions Master Title in World’s Largest AI Competition
23m ago	LTIMindtree : LTM has issued an offer to acquire Randstad’s Technology and Consulting Services business in Europe and Australia to scale domain-driven solutions and AI services
44m ago	Medline Inc. announces pricing of upsized secondary offering of Class A common stock
44m ago	iA Financial Group Announces Offering of $500 million of 4.158% Fixed/Floating Unsecured Subordinated Debentures

About

13.08USD+0.89 +7.30%

Closed • Updated at 03:45 GMT+00:00

Market Cap$1.10B

Volume1.89M

Beta0.50

RSI42.23

Health TechnologyPharmaceuticals: Major

Corvus Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Community Chat

Ask AI